AbbVie Gets More Humira Patent Claims Invalidated
AbbVie Inc. on Wednesday won another ruling in New York federal court declaring invalid patent claims for the anti-inflammatory drug Humira held by the Kennedy Institute of Rheumatology Trust, notching a...To view the full article, register now.
Already a subscriber? Click here to view full article